In this episode of The High Rise, Cy and Emily dive into the intriguing phenomenon of THC inflation in the cannabis industry. They begin by addressing Organigram's recent earnings call, where CEO Beena Goldenberg highlighted the issue of falsely labeled cannabis products with exaggerated THC levels. Shockingly, nearly 50% of cannabis flower sales in Q3 were found to be labeled as containing 26% or more THC, a figure that has doubled in the last 10 months. The hosts discuss the impact of THC inflation on consumer trust, market dynamics, and the need for regulatory enforcement.
https://mgmagazine.com/business/retail-merchandise/edibles-trending-toward-high-potency/
Related Episodes
E149: From Wheat to Weed: Commerce Clause and Cannabis
Join Emily and Cy as they host Darren Weiss, President of Verano as they discuss the genesis of the historic lawsuit filed against the federal government challenging cannabis prohibition under the Commerce Clause. The lawsuit argues that the federal government's current contradictory stance on...
E146 - High-Rise Live at Benzinga Chicago 2023 with Kris Krane
We are live! Or, were live for that matter. Cannabis pioneer Kris Krane joins the High Rise at Benzinga in Chicago to reflect on his 25+ year career. He discusses pivotal moments like legalization in 2012 and his shift from advocacy to industry. Krane also provides an insider perspective on dynamic...
E136 - Hold my beer while I throw a ‘Z’ at the end of my product name to avoid trademark infringement
In this episode of The High Rise, we delve into the latest news in the cannabis industry regarding a trademark infringement case. Tune in as we discuss the case involving the popular marijuana strain Zkittlez, which recently faced legal pressure from confectioner Wrigley, the owner of the Skittles ...